MSR1 and pulmonary fibrosis: Moreover, in mouse models of pulmonary fibrosis, the blockage of CD204 (by the action of a specific blocking monoclonal antibody) in M2 macrophages was shown to completely abrogate the development of fibrotic process [26–28].